Market Place
Sourcing Support
FDA Approves Ziihera for HER2-Positive Biliary Tract Cancer
21 Nov 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
21 Nov 2024 //
GLOBENEWSWIRE
Zymeworks Doses First Patient in ZW191 Phase 1 Solid Tumor Trial
05 Nov 2024 //
GLOBENEWSWIRE
Zymeworks Reports Q3 2024 Results & Corporate Update
31 Oct 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
29 Oct 2024 //
GLOBENEWSWIRE
Zymeworks Presents Preclinical Data on ADC Programs at EORTC
25 Oct 2024 //
GLOBENEWSWIRE
Zymeworks Doses First Patient In Phase 1 Trial Of ZW171
21 Oct 2024 //
GLOBENEWSWIRE
Zymeworks Reports Q3 2024 Results On October 31 2024
10 Oct 2024 //
GLOBENEWSWIRE
Zymeworks To Present ADC Data At EORTC-NCI-AACR Meeting
18 Sep 2024 //
GLOBENEWSWIRE
Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)
03 Sep 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
22 Aug 2024 //
GLOBENEWSWIRE
Zymeworks Reports Q2 2024 Results And Provides Corporate Update
01 Aug 2024 //
GLOBENEWSWIRE
Zymeworks Announces $60M Share Repurchase Program
01 Aug 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
30 Jul 2024 //
GLOBENEWSWIRE
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
25 Jul 2024 //
GLOBENEWSWIRE
Zymeworks` IND For ZW191 Folate Receptor-? ADC Cleared By FDA
22 Jul 2024 //
GLOBENEWSWIRE
Zymeworks To Report Q2 2024 Results On August 1
11 Jul 2024 //
GLOBENEWSWIRE
Zymeworks Announces FDA Clearance For ZW171 Bispecific Antibody For Cancer
17 Jun 2024 //
GLOBENEWSWIRE
Zymeworks Gets China BLA For Zanidatamab In Biliary Tract Cancer
10 Jun 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
28 May 2024 //
GLOBENEWSWIRE
Zymeworks Q1 2024 Results, Corporate Update
02 May 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
30 Apr 2024 //
GLOBENEWSWIRE
Zymeworks Q1 2024 Results, Call On 5/2
11 Apr 2024 //
GLOBENEWSWIRE
Zymeworks Presents Data from Multiple Preclinical Development Programs at AACR
08 Apr 2024 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
28 Mar 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
27 Mar 2024 //
GLOBENEWSWIRE
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Zymeworks to Present Data on ADC and Multispecific Platforms
05 Mar 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
27 Feb 2024 //
GLOBENEWSWIRE
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
14 Feb 2024 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Dr. Alessandra Cesano to Board of Directors
08 Feb 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
31 Jan 2024 //
GLOBENEWSWIRE
Zymeworks Announces Additional Leadership Appointments
04 Jan 2024 //
GLOBENEWSWIRE
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
04 Jan 2024 //
GLOBENEWSWIRE
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
26 Dec 2023 //
GLOBENEWSWIRE
Zymeworks Added to Nasdaq Biotechnology Index
15 Dec 2023 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conference
30 Nov 2023 //
GLOBENEWSWIRE
Zymeworks Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Zymeworks To Host Third Quarter 2023 Results Conference Call
17 Oct 2023 //
GLOBENEWSWIRE
Zymeworks Announces New Director Nominee
16 Oct 2023 //
GLOBENEWSWIRE
Zymeworks Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
01 Aug 2023 //
GLOBENEWSWIRE
Zymeworks To Host Second Quarter 2023 Results Conference Call
19 Jul 2023 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conference
03 Jul 2023 //
GLOBENEWSWIRE
Zymeworks Appoints New Director
29 Jun 2023 //
GLOBENEWSWIRE
Zymeworks Set to Join Russell 3000®, Russell 2000, and Russell Microcap® Indexes
26 Jun 2023 //
GLOBENEWSWIRE
Zymeworks to open new EU HQ in Dublin, Ireland
22 Jun 2023 //
PHARMAFILE
Jazz and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO
02 Jun 2023 //
PR NEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
01 Jun 2023 //
GLOBENEWSWIRE
Zymeworks Announces Departure of Neil Klompas, President and COO
18 May 2023 //
GLOBENEWSWIRE
Zymeworks Provides Corporate Update and Reports 1Q 2023 FYR
08 May 2023 //
GLOBENEWSWIRE
Zymeworks Presents New Data from Multiple Preclinical and Clinical Development
18 Apr 2023 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
10 Apr 2023 //
BUSINESSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
03 Apr 2023 //
BUSINESSWIRE
Daiichi and Zymeworks end antibody pact after seven years
21 Mar 2023 //
ENDPTS
Zymeworks to Present Data on Multiple Product Candidates at AACR
14 Mar 2023 //
BUSINESSWIRE
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
07 Mar 2023 //
BUSINESSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
28 Feb 2023 //
BUSINESSWIRE
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
21 Feb 2023 //
BUSINESSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
25 Jan 2023 //
BUSINESSWIRE
